HOME >> MEDICINE >> NEWS
Cincinnati surgeon's pediatric laparoscopic liver surgery a world first

CINCINNATI--A University of Cincinnati (UC) surgeon recently performed what is believed to be the world's first pediatric laparoscopic liver surgery, a specialized procedure for removing cancerous liver tumors without the need for a major incision.

Mark Thomas, MD, an assistant professor and transplant surgeon at UC, performed the operation in a 2-year-old boy with liver cancer on May 24 at La Raza Pediatric Medical Hospital in Mexico City.

Liver cancer is rare in children--less than 150 cases are diagnosed each year compared to more than 18,000 in adults--so the disease often misdiagnosed as constipation, food intolerance or anorexia until it is in an advanced and difficult-to-treat stage.

This patient's symptoms had been dismissed as such for several months before physicians confirmed he had hepatoblastoma of the liver, a type of cancer that starts in the organ's cells (hepatocytes) and develops into one or multiple tumors. Thomas was invited to the La Raza Pediatric Medical Hospital to perform the patient's surgery and teach two lectures on the specialized minimally invasive procedure.

Laparoscopic (minimally invasive) surgery is a method of operating inside the abdomen through small, tube-like ports using a fiber-optic light source, camera and specialized instruments. Known as laparoscopic liver resection, this procedure requires incisions so small (about three-inches) that they leave only minimal scarring.

Two months post-surgery, the patient is doing well and is expected to have a full recovery after several additional rounds of chemotherapy.

Thomas says the procedure is a safe, effective alternative to traditional "open" surgery for liver cancer--which requires up to a 30-inch incision. It also is available for patients with advanced liver disease who cannot tolerate the standard operation. The minimally invasive laparoscopic approach is most often used to remove liver tumors and treat other
'"/>

Contact: Amanda Harper
amanda.harper@uc.edu
513-558-4657
University of Cincinnati
7-Aug-2006


Page: 1 2 3

Related medicine news :

1. Cincinnati Childrens researchers publish findings on potential target for leukemia treatment
2. Verbal medical order errors reduced to zero, according to new Cincinnati Childrens study
3. Cincinnati surgeons report new treatment for often-fatal injury
4. Cincinnati Childrens applauds EU approval of rotavirus vaccine
5. Cincinnati Childrens scientist wins achievement award for advances in heart disease research
6. Univ. of Cincinnati receives $17.4 million grant to lead stroke study
7. 1 of 2 pediatric kidney disease research centers in world established
8. Wireless technology shows promise in diagnosing pediatric intestinal disease
9. Abilify sNDA for pediatric patients with schizophrenia accepted for priority FDA review
10. Study: Who claims to be a pediatrician?
11. Help for pediatricians in treating behavioral health problems only partially successful

Post Your Comments:
(Date:5/19/2013)... Aires, Argentina: Yoga classes ( clases de Yoga ) ... the Sivananda Yoga Vedanta Center. The center is ... Classes are 90 minutes and are offered all week ... calm environment, allowing visitors to enjoy the benefits of ... others. , The Yoga classes follow the following principles: ...
(Date:5/19/2013)... May 19, 2013 The legal team ... YazSideEffects.com in a concerted effort to connect women and ... birth control drugs Yaz, Yasmin & Ocella with the ... of information on the notorious birth control drugs as ... Pharmaceuticals. , Yaz, Yasmin & Ocella were very ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to announce ... Colston, Daily Gossip’s spokesperson, told the press that the magazine ... Fat Loss Plan . , Shaun Hadsall was the ... time when nutritionists and fat loss gurus constantly told people ... diet is based on the Macro-Patterning scheme, according ...
(Date:5/18/2013)... Also known as bariatric surgery , ... surgery that guarantees patients long-term weight loss. Dr. Naim ... give readers a brief tutorial on this revolutionary weight ... New York City’s Mount Sinai School of Medicine. After ... fellowship in Minimally Invasive Bariatric Surgery. He has also ...
(Date:5/18/2013)... News) -- Children who swallow high-powered magnets often need ... according to a new study. The researchers, from ... found that more than 79 percent of children who ... an endoscopic procedure, in which a tube containing a ... percent of these cases can be treated through observation ...
Breaking Medicine News(10 mins):Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2
(Date:5/16/2013)... and ZURICH , May 17, ... Agency for Science, Technology and Research (A*STAR) and ... first healthy volunteer has been dosed in a Phase 1 ... Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this ... this novel vaccine candidate and its potential to protect against ...
(Date:5/16/2013)... SAN FRANCISCO , May 16, 2013  Nektar Therapeutics, ... Howard W. Robin , is scheduled to ... New York at the Sheraton New ... Eastern time. The presentation will be accessible via ... Events Calendar section of the Nektar website: http://www.nektar.com . ...
(Date:5/16/2013)... , May 16, 2013  Alere Inc. (NYSE: ... take charge of their health at home through the merger ... dividend of $3.00 per share on its Series B Convertible ... July 15, 2013 to holders of record of Series B ... Such payment will cover the amount of all ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
Cached News: